-
Integrated genetic analysis of primary CNS lymphoma
Study
EGAS00001007222
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Study
EGAS00001005340
-
Targeted sequencing about core genes involved in telomere biology in colorectal cancer patients
Study
EGAS00001002977
-
Whole_Genome_Sequencing_of_Human_Organoid_Lines
Study
EGAS00001003538
-
Unraveling the transcriptomic profile of utero-tubal lavage fluid of ovarian cancer patients
Study
EGAS00001005498
-
Identification of the mutational consequences of precancerous liver disease (including alcohol abuse) on the genomes of human adult stem cells.
Study
EGAS00001002983
-
WGS_of_healhy_mesothelial_cells_and_primary_mesothelima_cell_lines
Study
EGAS00001005559
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Role_of_HPV_and_Interferon_in_APOBEC_mutational_signature
Study
EGAS00001002988
-
Early ctDNA molecular response captures therapeutic response in the first stage of CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer
Study
EGAS00001007298
-
Circulating tumor DNA, pathological and immunologic responses to neoadjuvant nivolumab or nivolumab plus relatlimab and chemoradiotherapy in resectable esophageal/gastroesophageal junction cancer
Study
EGAS00001007299
-
A benchmarking resource for NGS testing of cancer predisposition genes
Study
EGAS00001002993
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Epigenetic profiling of colorectal cancer initiating cells (CC-ICs) to identify bivalently marked genes (H3K4me3 and H3K27me3 ChIP-seq), and investigation of changes in transcriptome following EZH2 inhibition using RNA-seq.
Study
EGAS00001003003
-
Breast cancer sequencing data
Study
EGAS00001007336
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer
Study
EGAS00001007372
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___BD___WGS
Study
EGAS00001003014
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths
Study
EGAS00001007402
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030